George joined BMO Capital Markets Equity Research as an analyst covering Biotechnology in August 2018. Most recently, George was Chief Executive Officer of Cortice Biosciences, Inc., a privately held biotechnology company in New York City, and served as Vice President of Corporate Development at Synta Pharmaceuticals, a publicly traded drug development company in Boston. Prior to these positions, George was a Senior Biotechnology Analyst for 12 years, working with Canaccord Genuity, Wachovia Capital Markets, and Fortis Securities. George also completed postdoctoral fellowships at Sloan Kettering Cancer Center and University of California San Francisco after receiving his PhD from Columbia University. He also received a B.A. from Dartmouth College.
BMO Capital Markets is a trade name used by BMO Financial Group for the wholesale banking businesses of Bank of Montreal, BMO Harris Bank N.A. (member FDIC), Bank of Montreal Europe p.l.c, and Bank of Montreal (China) Co. Ltd, the institutional broker dealer business of BMO Capital Markets Corp. (Member FINRA and SIPC) and the agency broker dealer business of Clearpool Execution Services, LLC (Member FINRA and SIPC) in the U.S., and the institutional broker dealer businesses of BMO Nesbitt Burns Inc. (Member Investment Industry Regulatory Organization of Canada and Member Canadian Investor Protection Fund) in Canada and Asia, Bank of Montreal Europe p.l.c. (authorised and regulated by the Central Bank of Ireland) in Europe and BMO Capital Markets Limited (authorised and regulated by the Financial Conduct Authority) in the UK and Australia.